as 11-20-2024 4:00pm EST
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Founded: | 1892 | Country: | United States |
Employees: | N/A | City: | CHICAGO |
Market Cap: | 40.4B | IPO Year: | N/A |
Target Price: | $94.36 | AVG Volume (30 days): | 3.5M |
Analyst Decision: | Buy | Number of Analysts: | 14 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 3.65 | EPS Growth: | 8.27 |
52 Week Low/High: | $66.39 - $94.55 | Next Earning Date: | 10-30-2024 |
Revenue: | $19,559,000,000 | Revenue Growth: | 1.43% |
Revenue Growth (this year): | 2.77% | Revenue Growth (next year): | 4.14% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Rott Roland | GEHC | CEO, Imaging | Nov 5 '24 | Sell | $86.48 | 3,577 | $309,338.96 | 24,298 |
GEHC Breaking Stock News: Dive into GEHC Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Business Wire
8 days ago
Morningstar Research
9 days ago
Business Wire
9 days ago
Simply Wall St.
10 days ago
Business Wire
10 days ago
Business Wire
13 days ago
Business Wire
14 days ago
The information presented on this page, "GEHC GE HealthCare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.